Patents by Inventor Roland Segonds

Roland Segonds has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
    Patent number: 8476307
    Abstract: A pharmaceutical composition comprising idazoxan or derivatives and their therapeutically acceptable salts, racemates, optically active isomers and polymorphs.
    Type: Grant
    Filed: April 15, 2008
    Date of Patent: July 2, 2013
    Assignee: Pierre Fabre Medicament
    Inventors: Joel Bougaret, Jean-Louis Avan, Roland Segonds
  • Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
    Patent number: 8124640
    Abstract: Pharmaceutical composition comprising 5 to 20% of an idazoxan salt or of idazoxan hydrate, 10 to 40% of microcrystalline cellulose, 1 to 5% of lubricant, 0.1 to 0.5% of colloidal silica and from 29.5% to 84.8% of lactose, with respect to the total mass.
    Type: Grant
    Filed: January 17, 2008
    Date of Patent: February 28, 2012
    Assignee: Pierre Fabre Medicament
    Inventors: Joël Bougaret, Jean-Louis Avan, Roland Segonds
  • Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
    Patent number: 7595335
    Abstract: A pharmaceutical composition comprising idazoxan or derivatives and their therapeutically acceptable salts, racemates, optically active isomers and polymorphs.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: September 29, 2009
    Assignee: Pierre Fabre Medicament
    Inventors: Joël Bougaret, Jean-Louis Avan, Roland Segonds
  • PHARMACEUTICAL COMPOSITION BASED ON IDAZOXAN, SALTS, HYDRATES OR POLYMORPHS THEREOF
    Publication number: 20080113022
    Abstract: Pharmaceutical composition comprising 5 to 20% of an idazoxan salt or of idazoxan hydrate, 10 to 40% of microcrystalline cellulose, 1 to 5% of lubricant, 0.1 to 0.5% of colloidal silica and from 29.5% to 84.8% of lactose, with respect to the total mass.
    Type: Application
    Filed: January 17, 2008
    Publication date: May 15, 2008
    Inventors: Joël BOUGARET, Jean-Louis Avan, Roland Segonds
  • Pharmaceutical composition based on a polymorphic form I of idazoxan
    Patent number: 7338970
    Abstract: Pharmaceutical composition comprising 5 to 20% of an idazoxan salt or of idazoxan hydrate, 10 to 40% of microcrystalline cellulose, 1 to 5% of lubricant, 0.1 to 0.5% of colloidal silica and from 29.5% to 84.8% of lactose, with respect to the total mass.
    Type: Grant
    Filed: November 28, 2003
    Date of Patent: March 4, 2008
    Assignee: Pierre Fabre Medicament
    Inventors: Joël Bougaret, Jean-Louis Avan, Roland Segonds
  • Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
    Publication number: 20050176798
    Abstract: A pharmaceutical composition comprising idazoxan or derivatives and their therapeutically acceptable salts, racemates, optically active isomers and polymorphs.
    Type: Application
    Filed: October 28, 2004
    Publication date: August 11, 2005
    Applicant: Pierre Fabre Medicament
    Inventors: Joel Bougaret, Jean-Louis Avan, Roland Segonds
  • Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
    Publication number: 20050090537
    Abstract: Pharmaceutical composition comprising 5 to 20% of an idazoxan salt or of idazoxan hydrate, 10 to 40% of microcrystalline cellulose, 1 to 5% of lubricant, 0.1 to 0.5% of colloidal silica and from 29.5% to 84.8% of lactose, with respect to the total mass.
    Type: Application
    Filed: November 28, 2003
    Publication date: April 28, 2005
    Inventors: Joel Bougaret, Jean-Louis Avan, Roland Segonds